Actavis Acquisition of Warner Chilcott Clears Final Hurdle

It was four months ago that a definitive agreement was announced in which Actavis (NYSE: ACT  ) would acquire specialty pharma manufacturer Warner Chilcott (NASDAQ: WCRX  ) in an $8.5 billion, all-stock deal. The two companies said today in a statement that they have received approval from the Irish High Court, the last regulatory hurdle needed to move forward. Warner Chilcott is based in Dublin, Ireland. Actavis is based in New Jersey.

The Irish High Court's approval announced today followed Friday's news that the U.S. Federal Trade Commission voted to approve the deal, subject to certain conditions. Actavis, as a condition of its FTC approval, said it has agreed to divest itself of four generic drugs, which will revert to Amneal Pharmaceuticals. The drugs are the generic forms of Femcon Fe, Lo Loestrin Fe, Atelvia, and Loestrin 24 Fe.

According to today's statement, the only remaining steps before finalizing the deal are the "satisfaction of other customary closing conditions." The transaction is expected to close shortly after those conditions are addressed, the companies said.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2661095, ~/Articles/ArticleHandler.aspx, 12/18/2014 2:26:27 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement